News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
631,635 Results
Type
Article (60801)
Company Profile (196)
Press Release (570638)
Section
Business (181458)
Career Advice (2057)
Deals (28521)
Drug Delivery (107)
Drug Development (68002)
Employer Resources (169)
FDA (14573)
Job Trends (14000)
News (299918)
Policy (29463)
Tag
Academia (2934)
Alliances (47166)
Alzheimer's disease (1192)
Approvals (14512)
Artificial intelligence (144)
Bankruptcy (251)
Best Places to Work (11308)
Biotechnology (121)
Breast cancer (115)
Cancer (986)
Cardiovascular disease (93)
Career advice (1764)
Cell therapy (222)
Clinical research (53291)
Collaboration (385)
COVID-19 (2617)
C-suite (99)
Data (1037)
Diabetes (145)
Diagnostics (6096)
Drug pricing (93)
Earnings (67797)
Employer resources (146)
Events (102944)
Executive appointments (311)
FDA (15067)
Funding (345)
Gene therapy (172)
GLP-1 (586)
Government (4633)
Healthcare (18583)
Infectious disease (2706)
Inflammatory bowel disease (107)
Interviews (337)
IPO (12498)
Job creations (3066)
Job search strategy (1523)
Layoffs (330)
Legal (6785)
Lung cancer (159)
Manufacturing (176)
Medical device (12203)
Medtech (12207)
Mergers & acquisitions (16116)
Metabolic disorders (406)
Neuroscience (1449)
NextGen Class of 2024 (6594)
Non-profit (4744)
Northern California (1302)
Obesity (240)
Opinion (194)
Patents (90)
People (53573)
Phase I (16749)
Phase II (22694)
Phase III (17895)
Pipeline (438)
Postmarket research (2611)
Preclinical (7286)
Radiopharmaceuticals (225)
Rare diseases (202)
Real estate (5225)
Regulatory (19227)
Research institute (2471)
Resumes & cover letters (299)
Southern California (1102)
Startups (3349)
United States (12173)
Vaccines (578)
Weight loss (183)
Date
Last 7 days (616)
Last 30 days (3148)
Last 365 days (32805)
2024 (30100)
2023 (36701)
2022 (47288)
2021 (51638)
2020 (50839)
2019 (45121)
2018 (34020)
2017 (29575)
2016 (30333)
2015 (34674)
2014 (28427)
2013 (25552)
2012 (26608)
2011 (26409)
2010 (24865)
Location
Africa (930)
Arizona (152)
Asia (36342)
Australia (6586)
California (2834)
Canada (1177)
China (230)
Colorado (147)
Connecticut (153)
Europe (84519)
Florida (419)
Georgia (115)
Illinois (342)
Indiana (198)
Kansas (88)
Maryland (531)
Massachusetts (2282)
Michigan (166)
Minnesota (241)
New Jersey (892)
New York (890)
North Carolina (700)
Northern California (1302)
Ohio (129)
Pennsylvania (734)
South America (1212)
Southern California (1102)
Texas (396)
Utah (91)
Washington State (337)
631,635 Results for "oregon health and science university ohsu".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning
RaySearch Laboratories AB announces that Oregon Health & Science University in the USA has placed an order for the treatment planning system RayStation®*.
October 31, 2023
·
1 min read
Business
Skanska signs additional contract to expand hospital in Portland, Oregon, USA, for USD 200M, about SEK 2.1 billion
Skanska has signed an additional contract with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.
December 22, 2023
·
1 min read
Biotech Beach
Biological Dynamics and Oregon Health & Science University Collaborate on Early-Stage Pancreatic Cancer Detection Study
Biological Dynamics, Inc., a company developing and commercializing its exosome-isolation ExoVerita™ platform for early disease diagnostics and other applications, announced its collaboration with the Brenden-Colson Center for Pancreatic Care at Oregon Health & Science University to study its ExoVita™ Pancreas assay.
March 1, 2023
·
3 min read
Business
Castle Biosciences Announces Support for OHSU’s War on Melanoma™
Oregon Health & Science University (OHSU) launched the War on Melanoma to eliminate melanoma as a cause of death.
June 20, 2022
·
3 min read
Linear Health Sciences Reports Clinical, Commercial Milestones
Medical device company Linear Health Sciences today announced multiple clinical and commercial milestones for its Orchid SRV™ , a breakaway safety valve designed to improve the use of medical tubing in hospitals.
June 26, 2024
·
3 min read
Deals
Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023
Seres Therapeutics, Inc., announced that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST capsules.
June 6, 2024
·
4 min read
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of The State of Oregon Agriculture Fertilizer Registration Certificate
February 6, 2024
·
7 min read
Skanska signs additional contract to expand hospital in Portland, Oregon, USA, for USD 111M, about SEK 1.2 billion
Skanska has signed a contract amendment with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.
April 4, 2023
·
1 min read
Deals
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights.
June 6, 2024
·
5 min read
Lone Star Bio
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Lantern Pharma Inc. announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications.
May 6, 2024
·
15 min read
1 of 63,164
Next
